Literature DB >> 34153991

Sterilization Modality Selection: Role of Sterility Assurance Subject Matter Expert.

Jami McLaren, Joyce M Hansen, Vu Le.   

Abstract

Selection of a sterilization modality for a medical device is a critical decision that requires sterility assurance subject matter experts (SME)s to work collaboratively with various company functions. The sterility assurance SME is responsible and accountable for the sterilization modality decision for a product. The modality selection process starts with the sterility assurance SME partnering with research and development to ensure that the sterilization modality allows the device to deliver its intended function in patient care. After the sterilization modality is selected, the sterility assurance SME needs to work with other partners, including quality, supply chain/logistics, operations, and regulatory, to ensure that the selected sterilization modality is appropriately integrated into the end-to-end process. Collaborative partnerships between sterility assurance experts and key partners regarding sterilization modality selection reduce the potential for negative impacts within the end-to-end sterility assurance process, including impacts on product functionality, increased regulatory approval timelines, and inefficiencies and risks throughout the supply chain. This article describes aspects of a comprehensive approach to sterilization modality selection, including critical information necessary to address each of the key considerations. © Copyright AAMI 2021. Copying, networking, and distribution prohibited.

Entities:  

Mesh:

Year:  2021        PMID: 34153991      PMCID: PMC8655698          DOI: 10.2345/0899-8205-55.s3.67

Source DB:  PubMed          Journal:  Biomed Instrum Technol        ISSN: 0899-8205


  1 in total

Review 1.  Medical Device Sterilization Modality Selection Decision Process.

Authors:  Jami McLaren
Journal:  Biomed Instrum Technol       Date:  2020-06-01
  1 in total
  1 in total

1.  Efficacy of Letrozole Combined with Urinary Gonadotropin for Ovulation Induction in Endocrine Abnormal Infertility Patients: A Retrospective Single-Center, Case-Control Study.

Authors:  Hao Peng; Ben Yuan; Junbiao Mao; Junling Wang; Shuhong Luo
Journal:  Comput Math Methods Med       Date:  2022-07-11       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.